RaySearch appoints new CFO
RaySearch Laboratories AB (publ) announces that Nina Grönberg has been appointed new CFO of the company, taking up her position 27 January 2025.
Nina has extensive experience from leadership positions in the finance field in several international and publicly listed companies. She most recently held the role of CFO in the healthcare company Team Olivia, and prior to that, CFO at Duroc, as well as leading roles in accounting, reporting, and business control at Ratos and Munters.
Nina Grönberg says: “RaySearch is an innovative company and a driving force in the fight against cancer. The finance function has an important role to play in this exciting phase of expansion that RaySearch is currently undergoing.”
Johan Löf, founder and CEO, RaySearch, says: “I am very happy to welcome Nina to the position as CFO of RaySearch. With her extensive experience in finance and strong leadership skills, I am confident that she will play a key role in driving the company's continued growth."
As previously communicated Annika Blondeau Henriksson has been interim CFO since July 2023. Annika will remain interim CFO until Nina takes up the position as CFO.
FOR MORE INFORMATION PLEASE CONTACT:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
johan.lof@raysearchlabs.com
Learn more about us on:
LinkedIn
YouTube
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch's software has been sold to over 1,000 clinics in 44 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
* Subject to regulatory clearance in some markets.
Tags: